Skip to content
← All treatment topics

TREATMENT READING

Childhood Thymoma and Thymic Carcinoma

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

26 sections
  1. Types of treatment for childhood thymoma and thymic carcinoma
  2. Who treats children with thymoma and thymic carcinoma?
  3. Surgery
  4. Radiation therapy
  5. Chemotherapy
  6. Hormone therapy
  7. Targeted therapy
  8. Clinical trials
  9. Treatment of childhood thymoma
  10. Treatment of newly diagnosed thymoma may include:
  11. Treatment of childhood thymic carcinoma
  12. Side effects and late effects of treatment
  13. Treatment of Childhood Thymoma
  14. Surgery
  15. Radiation therapy
  16. Chemotherapy
  17. Octreotide
  18. Sunitinib
  19. Treatment Options Under Clinical Evaluation for Childhood Thymoma
  20. Treatment of Childhood Thymic Carcinoma
  21. Surgery
  22. Radiation therapy
  23. Chemotherapy
  24. Sunitinib
  25. Treatment Options Under Clinical Evaluation for Childhood Thymic Carcinoma
  26. Special Considerations for the Treatment of Children With Cancer

For patients

Types of treatment for childhood thymoma and thymic carcinoma

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Types of treatment for childhood thymoma and thymic carcinoma

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

For patients · Types of treatment for childhood thymoma and thymic carcinoma

Who treats children with thymoma and thymic carcinoma?

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

A pediatric oncologist, a doctor who specializes in treating children with cancer, oversees the treatment of thymoma and thymic carcinoma. The pediatric oncologist works with other health care providers who are experts in treating children with thymoma or thymic carcinoma and specialize in certain areas of medicine. Other specialists may include:

pediatrician

Sources: pediatrician

pediatric surgeon

Sources: pediatric surgeon

radiation oncologist

Sources: radiation oncologist

pathologist

Sources: pathologist

pediatric nurse specialist

Sources: pediatric nurse specialist

social worker

Sources: social worker

rehabilitation specialist

Sources: rehabilitation specialist

psychologist

Sources: psychologist

child-life specialist

Sources: child-life specialist

fertility specialist

Sources: fertility specialist

There are different types of treatment for children and adolescents with thymoma or thymic carcinoma. You and your child’s care team will work together to decide treatment. Many factors will be considered, such as your child’s overall health and whether the tumor is newly diagnosed or has come back.

Your child’s treatment plan will include information about the tumor, the goals of treatment, treatment options, and the possible side effects. It will be helpful to talk with your child’s care team before treatment begins about what to expect. For help every step of the way, see our booklet, Children with Cancer: A Guide for Parents.

Sources: Children with Cancer: A Guide for Parents

The following types of treatment may be used:

For patients · Types of treatment for childhood thymoma and thymic carcinoma

Surgery

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Surgery to remove the cancer is the main treatment for thymoma and thymic carcinoma. However, thymic carcinoma can rarely be completely removed by surgery and is likely to recur (come back) after treatment.

For patients · Types of treatment for childhood thymoma and thymic carcinoma

Radiation therapy

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. Thymoma and thymic carcinoma are treated with external beam radiation therapy. This type of therapy uses a machine outside the body to send radiation toward the area of the body with cancer. Radiation therapy may be given alone or with other treatments, such as chemotherapy.

Sources: x-rays

To learn more, see External Beam Radiation Therapy for Cancer and Radiation Therapy Side Effects.

Sources: External Beam Radiation Therapy for Cancer · Radiation Therapy Side Effects

For patients · Types of treatment for childhood thymoma and thymic carcinoma

Chemotherapy

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Chemotherapy (also called chemo) uses drugs to stop the growth of cancer cells. Chemotherapy either kills cancer cells or stops them from dividing. Chemotherapy may be given alone or with other types of treatment.

For thymoma and thymic carcinoma, chemotherapy is injected into a vein. When given this way, the drugs enter the bloodstream and can reach cancer cells throughout the body.

Sources: injected

Chemotherapy drugs used alone or in combination to treat thymoma and thymic carcinoma include:

cisplatin

Sources: cisplatin

cyclophosphamide

Sources: cyclophosphamide

doxorubicin

Sources: doxorubicin

etoposide

Sources: etoposide

ifosfamide

Sources: ifosfamide

vincristine

Sources: vincristine

Other chemotherapy drugs not listed here may also be used.

To learn more about how chemotherapy works, how it is given, common side effects, and more, see Chemotherapy to Treat Cancer.

Sources: Chemotherapy to Treat Cancer

For patients · Types of treatment for childhood thymoma and thymic carcinoma

Hormone therapy

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Hormone therapy removes hormones or blocks their action, stopping cancer cells from growing. Hormones are substances that are made by glands in the body and flow through the bloodstream. Some hormones can cause certain cancers to grow. If tests show that the cancer cells have places where hormones can attach (receptors), drugs may be used to reduce the production of hormones or block them from working.

Sources: glands

Hormone therapy used for thymoma may include octreotide with or without prednisone.

Sources: prednisone

For patients · Types of treatment for childhood thymoma and thymic carcinoma

Targeted therapy

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, or other molecules involved in the growth and spread of cancer cells. Sunitinib is used to treat thymoma and thymic carcinoma that has not responded to other treatments.

Sources: enzymes · Sunitinib

Learn more about Targeted Therapy to Treat Cancer.

Sources: Targeted Therapy to Treat Cancer

For patients · Types of treatment for childhood thymoma and thymic carcinoma

Clinical trials

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Joining a clinical trial may be an option. There are different types of clinical trials for childhood cancer. For example, a treatment trial tests new treatments or new ways of using existing treatments. Supportive care and palliative care trials look at ways to improve quality of life, especially for those who have side effects from cancer and its treatment.

You can use the clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. The search allows you to filter trials based on the type of cancer, your child’s age, and where the trials are being done.

Sources: clinical trial search

To learn more, see Clinical Trials Information for Patients and Caregivers.

Sources: Clinical Trials Information for Patients and Caregivers

For patients

Treatment of childhood thymoma

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Treatment of childhood thymoma

For patients · Treatment of childhood thymoma

Treatment of newly diagnosed thymoma may include:

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

surgery to remove as much of the tumor as possible

radiation therapy for tumors that cannot be removed by surgery or if some of the tumor remains after surgery

chemotherapy for tumors that did not respond to other treatments

Sources: respond

hormone therapy (octreotide) for tumors that did not respond to other treatments

Sources: octreotide

targeted therapy (sunitinib) for tumors that did not respond to other treatments

Sources: sunitinib

For patients

Treatment of childhood thymic carcinoma

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Treatment of childhood thymic carcinoma

Treatment of newly diagnosed thymic carcinoma may include:

surgery to remove as much of the tumor as possible

radiation therapy, for tumors that cannot be removed by surgery or if some of the tumor remains after surgery

chemotherapy for tumors that did not respond to radiation therapy

Sources: respond

targeted therapy (sunitinib) for tumors that did not respond to other treatments

Sources: sunitinib

If the cancer comes back after treatment, your child's doctor will talk with you about what to expect and possible next steps. There might be treatment options that may shrink the cancer or control its growth. If there are no treatments, your child can receive care to control symptoms from cancer so they can be as comfortable as possible.

For patients

Side effects and late effects of treatment

Source: Childhood Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: Not stated in this source. Captured 2026-09-09.

Side effects and late effects of treatment

Cancer treatments can cause side effects. Which side effects your child might have depends on the type of treatment they receive, the dose, and how their body reacts. Talk with your child's treatment team about which side effects to look for and ways to manage them.

To learn about side effects that begin during treatment for cancer, see Side Effects of Cancer Treatment.

Sources: Side Effects of Cancer Treatment.

Problems from cancer treatment that begin 6 months or later after treatment and continue for months or years are called late effects. Late effects of cancer treatment may include:

physical problems

changes in mood, feelings, thinking, learning, or memory

second cancers (new types of cancer) or other conditions

Sources: second cancer

Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments. To learn more, see Late Effects of Treatment for Childhood Cancer.

Sources: Late Effects of Treatment for Childhood Cancer

Health professional · Childhood Thymoma

Treatment of Childhood Thymoma

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Treatment options for childhood thymoma include the following:

Surgery.

Sources: Surgery

Radiation therapy.

Sources: Radiation therapy

Chemotherapy.

Sources: Chemotherapy

Octreotide.

Sources: Octreotide

Sunitinib.

Sources: Sunitinib

Health professional · Childhood Thymoma / Treatment of Childhood Thymoma

Surgery

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Surgery is the mainstay of therapy, and an attempt should be made to resect all disease.[8]

Sources: 8

Health professional · Childhood Thymoma / Treatment of Childhood Thymoma

Radiation therapy

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Thymoma is relatively radiosensitive, and radiation therapy is used for patients with unresectable or incompletely resected invasive disease.[7] Radiation dosage recommendations are based on the age of the child and the extent of tumor invasion. Total doses of 45 Gy to 50 Gy may be used for control of clear or close margins, 54 Gy for microscopically positive margins, and at least 60 Gy for patients with bulky residual disease.[9]

Sources: 7 · 9

Health professional · Childhood Thymoma / Treatment of Childhood Thymoma

Chemotherapy

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Chemotherapy is usually reserved for patients with advanced-stage disease who have not responded to radiation therapy or corticosteroids. Agents that have been effective include doxorubicin, cyclophosphamide, etoposide, cisplatin, ifosfamide, and vincristine.[1,7,10] Responses to regimens containing combinations of some of these agents have ranged from 26% to 100%, and survival rates have been as high as 50%.[9-12]

Sources: 1 · 7 · 10 · 9 · 12

Health professional · Childhood Thymoma / Treatment of Childhood Thymoma

Octreotide

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Because thymoma shows high uptake of indium In 111–labeled octreotide, trials using this somatostatin analogue have been conducted in patients with refractory disease. In an Eastern Cooperative Oncology Group phase II trial of 42 patients, 4 patients had partial responses to octreotide alone, and 8 patients responded with the addition of prednisone to octreotide.[13]

Sources: 13

Health professional · Childhood Thymoma / Treatment of Childhood Thymoma

Sunitinib

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

In an open-label phase II study of sunitinib in adult patients with refractory thymomas, partial responses were observed in 6% of patients, and stable disease was achieved in 75% of patients.[14]

Sources: 14

For more information about the treatment of thymomas, see Thymoma and Thymic Carcinoma Treatment.

Sources: Thymoma and Thymic Carcinoma Treatment

Health professional · Childhood Thymoma

Treatment Options Under Clinical Evaluation for Childhood Thymoma

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.

Sources: NCI website · ClinicalTrials.gov website

Health professional · Childhood Thymic Carcinoma

Treatment of Childhood Thymic Carcinoma

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Treatment options for childhood thymic carcinoma include the following:

Surgery.

Sources: Surgery

Radiation therapy.

Sources: Radiation therapy

Chemotherapy.

Sources: Chemotherapy

Sunitinib.

Sources: Sunitinib

Health professional · Childhood Thymic Carcinoma / Treatment of Childhood Thymic Carcinoma

Surgery

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Surgery is the mainstay of therapy, and an attempt should be made to resect all disease.[2]

Sources: 2

Health professional · Childhood Thymic Carcinoma / Treatment of Childhood Thymic Carcinoma

Radiation therapy

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Thymic carcinoma is relatively radiosensitive, and radiation therapy is used for patients with unresectable or incompletely resected invasive disease.[3] Radiation dosage recommendations are based on the age of the child and the extent of tumor invasion. Total doses of 45 Gy to 50 Gy may be used for control of clear or close margins, 54 Gy for microscopically positive margins, and at least 60 Gy for patients with bulky residual disease.[4]

Sources: 3 · 4

Health professional · Childhood Thymic Carcinoma / Treatment of Childhood Thymic Carcinoma

Chemotherapy

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Response rates are lower for patients with thymic carcinomas who receive chemotherapy, but 2-year survival rates have been as high as 50%.[5-7]

Sources: 5 · 7

For more information, see the Treatment of Childhood Thymoma section.

Sources: Treatment of Childhood Thymoma

Health professional · Childhood Thymic Carcinoma / Treatment of Childhood Thymic Carcinoma

Sunitinib

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

In an open-label phase II study of sunitinib in adult patients with refractory thymic carcinomas, partial responses were observed in 26% of patients, and stable disease was achieved in 65% of patients.[8]

Sources: 8

For more information about the treatment of thymic carcinomas in adults, see Thymoma and Thymic Carcinoma Treatment.

Sources: Thymoma and Thymic Carcinoma Treatment

Health professional · Childhood Thymic Carcinoma

Treatment Options Under Clinical Evaluation for Childhood Thymic Carcinoma

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.

Sources: NCI website · ClinicalTrials.gov website

Health professional

Special Considerations for the Treatment of Children With Cancer

Source: Childhood Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 12, 2024. Captured 2026-09-09.

Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:

Sources: 1

Primary care physicians.

Pediatric surgeons.

Pathologists.

Pediatric radiation oncologists.

Pediatric medical oncologists and hematologists.

Ophthalmologists.

Rehabilitation specialists.

Pediatric oncology nurses.

Social workers.

Child-life professionals.

Psychologists.

Nutritionists.

For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.

Sources: Supportive and Palliative Care

The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.

Sources: 2 · NCI website

Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.

Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer

Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.

Sources: 6 · Rare Diseases Act of 2002

The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:

Sources: 7 · 8

A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]

Sources: 9

The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.

Sources: 10 · 4

These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.

Information about these tumors may also be found in sources relevant to adults with cancer, such as Thymoma and Thymic Carcinoma Treatment.

Sources: Thymoma and Thymic Carcinoma Treatment